The Lancet
Cagrilintide for weight management in overweight or obesity
2021 · PMID 34481571
Lau DCW et al.
View source
Metabolic Compound
Fixed-ratio research blend combining cagrilintide (amylin analog) with semaglutide-class GLP-1 receptor agonist for dual-pathway laboratory studies.
Est. delivery Thu, Jul 30–Wed, Aug 5 · COA included · Same-day ship before 2PM PT
Apple Pay · Google Pay · Visa · Amex · Discover
Compound information
Technical specifications for laboratory reference
Molecular profile
Fixed-ratio research blend combining cagrilintide (amylin analog) with semaglutide-class GLP-1 receptor agonist for dual-pathway laboratory studies.
Storage requirements
Lyophilized (powder)
−20°C · up to 24 months
Reconstituted
2–8°C · up to 14 days
Literature
Peer-reviewed research for laboratory background
The Lancet
2021 · PMID 34481571
Lau DCW et al.
View sourceThe New England Journal of Medicine
2021 · PMID 33567185
Wilding JPH et al.
View sourceCitations are provided for research background only. Peptide Club materials are sold for laboratory research use — not for human or veterinary consumption. References do not constitute product claims.
Quality documentation
Third-party tested · batch-specific results
99.9%purity
Passed full QC panel
Batch COA PDF not linked yet for this variant. Email support@peptideclub.com or browse all COAs.